Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange
Alpha Tau Medical's ordinary shares will be added to the Tel Aviv Stock Exchange's TA-90 and TA-125 benchmark indices effective Nov. 5, 2026, within months of its August 2026 dual listing on Nasdaq and TASE. Index funds tracking these benchmarks are expected to add Alpha Tau shares to their holdings, and the company will be one of only three biomed names in the TA-125.
Key figures
- Indices
- ["TA-90","TA-125"]
- Biomed companies in ta125
- 3
- Index inclusion effective date
- Nov. 5, 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.